SK bioscience Co.,Ltd. (KRX:302440)
South Korea · Delayed Price · Currency is KRW 53,100
-1,500 (-2.75%)
At close: Nov 18, 2025
SK bioscience Market Cap
SK bioscience has a market cap or net worth of 4.16 trillion as of November 18, 2025. Its market cap has decreased by -5.82% in one year.
Market Cap
4.16T
Enterprise Value
3.81T
Revenue
534.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
53,100.00
Market Cap Chart
Since March 18, 2021, SK bioscience's market cap has decreased from 12.93T to 4.16T, a decrease of -67.81%. That is a compound annual growth rate of -21.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2025 | 4.16T | 5.39% |
| Dec 30, 2024 | 3.95T | -28.57% |
| Dec 28, 2023 | 5.53T | -2.04% |
| Dec 29, 2022 | 5.64T | -67.21% |
| Dec 30, 2021 | 17.21T | 33.14% |
| Mar 18, 2021 | 12.93T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 43.20T |
| ALTEOGEN | 29.63T |
| SK Biopharmaceuticals | 10.05T |
| ABL Bio | 9.60T |
| Yuhan | 9.35T |
| Peptron | 7.22T |
| HLB Co., Ltd. | 6.50T |